Follow-up information on the expected shortage of human tetanus immunoglobulin-containing medicinal product
03.02.2014
Following to the Information on the expected shortage of medicinal products produced by Imunološki zavod d.d., published on the 23 October 2013 with the aim to ensure an adequate market supply with medicines, HALMED wants to highlight that there is no other human tetanus immunoglobulin-containing medicinal product authorised in Croatia, therefore the Croatian market may be supplied only with a medicinal product not authorised in Croatia.
Due to the aforementioned, we invite wholesale license holders to act according to the legal obligation to ensure prompt, permanent and adequate supply of the Croatian market and find the medicinal product of another manufacturer and submit an application to HALMED for import of the medicinal product not authorised in Croatia ("interventional import”).
According to the recent available data on the human tetanus immunoglobulin, 250 IU, produced by Imunološki zavod, the stocks should be available for the next 2.5-3 months period.
